The Washington Manual Hematology and Oncology Subspecialty Consult: The Washington Manual Subspecialty Consult Series
Autor Brian A. Van Tine MDen Limba Engleză Paperback – 23 noi 2024
- Thoroughly revised to include new therapies such as PD-1 inhibitors for Hodgkin lymphoma, CAR T-cell therapy in NHL and multiple myeloma, gene therapy for sickle cell disease, CAR T-cell therapies and management of CRS and neurotoxicity, and more
- It presents clinically oriented information like symptoms, signs, and problems in a quick-reference, bulleted list format for easy, everyday reference
- Shares the knowledge and experience of a new co-editor of the Hematology section, Dr. Meagan Jacoby
- Provides updated references for additional information on key topics
- Written by fellows and faculty from the Washington University School of Medicine in St. Louis
- Read directly on your preferred device(s),such as computer, tablet, or smartphone.
- Easily convert to audiobook,powering your content with natural language text-to-speech.
Preț: 379.13 lei
Preț vechi: 465.01 lei
-18% Nou
Puncte Express: 569
Preț estimativ în valută:
72.57€ • 75.47$ • 60.81£
72.57€ • 75.47$ • 60.81£
Carte disponibilă
Livrare economică 21 februarie-05 martie
Livrare express 06-12 februarie pentru 104.11 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781975212841
ISBN-10: 1975212843
Pagini: 575
Dimensiuni: 127 x 203 x 23 mm
Greutate: 0.64 kg
Ediția:Fifth
Editura: LWW
Colecția Lww
Seria The Washington Manual Subspecialty Consult Series
ISBN-10: 1975212843
Pagini: 575
Dimensiuni: 127 x 203 x 23 mm
Greutate: 0.64 kg
Ediția:Fifth
Editura: LWW
Colecția Lww
Seria The Washington Manual Subspecialty Consult Series
Descriere
Concise, portable, and user-friendly, The Washington Manual Hematology and Oncology Subspecialty Consult, 5th Edition, provides quick access to the essential information needed to evaluate a patient on a hematology-oncology subspecialty consult service. Edited by Drs. Brian A. Van Tine and Meagan A. Jacoby, this best-selling manual offers state-of-the-art content, including coverage of new therapies such as CAR T-cell therapy, new anti-cancer drugs, and new biomarkers and therapeutic targets. Ideal for fellows, residents, and medical students rotating on hematology and oncology subspecialty services, the manual is also useful as a first-line resource for advanced practice providers, general internal medicine physicians, Hem/ONC fellows, and other primary care providers.